-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Royal DSM, a global scientific company active in nutrition, health and green life, announced that it has reached a value of up to 765 million euros with Glycom A/S (Glycom), the world's important supplier of breast milk oligosaccharides (HMO).
HMOs are a series of sugar structures present in human breast milk that act as prebiotics in the newborn, feeding probiotics in the gut and helping to foster a healthy microbial community
Founded in Denmark in 2005, Glycom has more than 150 employees and specializes in the development and commercialization of HMO products for early life nutrition
DSM is a leading global provider of early life nutrition solutions, with a wide range of specialty products including nutritional lipids, vitamins and nutrient premixes
This transaction will be a wonderful win-win case
Geraldine Matchett and Dimitri de Vreeze, Co-CEOs of Royal DSM, said: “We cannot wait to welcome Glycom to DSM
Odd Hansen, CEO of Glycom, added: "I am delighted to join DSM
The transaction is expected to close in the second quarter of 2020
DSM – Bright Technology, Better Life™
Royal DSM is a mission-oriented global science company active in nutrition, health and green living around the world, dedicated to creating a better life with colorful technology
DSM in China
DSM started trading with China as early as 1963 and established its first sales representative office and first production site in China in the early 1990s